Skip to content
OpenCapital
Get started

Artivion AORT Free cash flow

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$21.1M-109%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$12.31M+60.8%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
ITG
Integer HoldingsITGR
$737K-87.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%

Valuation

See full
Market cap$1.07B-24.8%
Enterprise value$1.27B-27.2%
P/E91.5×—
P/S2.3×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Calculated from Artivion’s reported figures.

$1.2Mnet cash from operating−$8.0Mcapital expenditures=-$6.85M

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's free cash flow?
Artivion (AORT) reported free cash flow of -$6.85M in Q1 2026.
How has Artivion's free cash flow changed year-over-year?
Artivion's free cash flow increased by 66.7% year-over-year, from -$20.59M to -$6.85M.
What is the long-term trend for Artivion's free cash flow?
Over 3 years (2021 to 2024), Artivion's free cash flow has grown at a -11.0% compound annual growth rate (CAGR), from -$15.68M to $11.05M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.